MedPath

Effects of ?3-fatty acid supplement on blood vascular and systemic inflammation markers, oxidative stress , hematologic indices and Lp(a) in hemodialysis patients

Not Applicable
Conditions
hemodialyzed patient in Sabzevar.
Kidney dialysis
Registration Number
IRCT138901263719N1
Lead Sponsor
Institute of Nurition Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Agreeing to enrol , at least six month past haemodialysis. Exclusion criteria: No infectious diseases, hepatic diseases, Lupus and rheumatoid arthritis, BMI<18.5 or BMI>25, consuming any the drugs including steroid, NSAID, statins, estrogens, progesterone, niacin and E or C vitamins one month prior to the study

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath